451 related articles for article (PubMed ID: 27930920)
1. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
[TBL] [Abstract][Full Text] [Related]
2. IDO inhibits T-cell function through suppressing Vav1 expression and activation.
Li R; Wei F; Yu J; Li H; Ren X; Hao X
Cancer Biol Ther; 2009 Jul; 8(14):1402-8. PubMed ID: 19597340
[TBL] [Abstract][Full Text] [Related]
3. Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1.
García-Bernal D; Wright N; Sotillo-Mallo E; Nombela-Arrieta C; Stein JV; Bustelo XR; Teixidó J
Mol Biol Cell; 2005 Jul; 16(7):3223-35. PubMed ID: 15872091
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
Tanizaki Y; Kobayashi A; Toujima S; Shiro M; Mizoguchi M; Mabuchi Y; Yagi S; Minami S; Takikawa O; Ino K
Cancer Sci; 2014 Aug; 105(8):966-73. PubMed ID: 24826982
[TBL] [Abstract][Full Text] [Related]
5. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
[TBL] [Abstract][Full Text] [Related]
6. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
7. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.
Godin-Ethier J; Hanafi LA; Duvignaud JB; Leclerc D; Lapointe R
Mol Immunol; 2011 Oct; 49(1-2):253-9. PubMed ID: 21937116
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
11. Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.
Sun J; Yu J; Li H; Yang L; Wei F; Yu W; Liu J; Ren X
J Exp Clin Cancer Res; 2011 Sep; 30(1):82. PubMed ID: 21917155
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
Katz JB; Muller AJ; Prendergast GC
Immunol Rev; 2008 Apr; 222():206-21. PubMed ID: 18364004
[TBL] [Abstract][Full Text] [Related]
13. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
[TBL] [Abstract][Full Text] [Related]
15. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.
Zhang G; Liu WL; Zhang L; Wang JY; Kuang MH; Liu P; Lin YH; Dai SQ; Du J
Clin Dev Immunol; 2011; 2011():384726. PubMed ID: 22013481
[TBL] [Abstract][Full Text] [Related]
16. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
17. Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells.
Villalba M; Bi K; Rodriguez F; Tanaka Y; Schoenberger S; Altman A
J Cell Biol; 2001 Oct; 155(3):331-8. PubMed ID: 11684704
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.
Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):56-67. PubMed ID: 29512370
[TBL] [Abstract][Full Text] [Related]
20. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.
Swanson KA; Zheng Y; Heidler KM; Mizobuchi T; Wilkes DS
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):311-8. PubMed ID: 12959949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]